Evidence Review
Trout vs. fish-oil capsules — Zibaeenezhad 2017 RCT
A particularly useful study for the trout-versus-supplement question is the open-label randomized trial by Zibaeenezhad and colleagues at Shiraz University of Medical Sciences [1]. They enrolled 95 adults with hyperlipidemia and randomized them either to 2 g/day of fish-oil capsules or to two 250 g portions of fresh trout per week, for 8 weeks. Both groups improved on triglycerides and total cholesterol, but the most striking divergence was on LDL: LDL rose in the supplement group while it fell significantly in the fresh-fish group. Total cholesterol-to-HDL and LDL-to-HDL ratios also improved more in the trout group. The authors framed this as evidence that the whole food matrix — protein, peptides, vitamin D, selenium, astaxanthin, and the lipid carriers in fish flesh — produces a more favorable lipid response than isolated triglyceride-form omega-3 oil. Limitations are real: small sample, short duration, single-center, open-label, and a population with hyperlipidemia rather than healthy controls. Even so, the head-to-head design is uncommon and the LDL divergence is hard to dismiss.
Population-level cardiovascular signal — Mohan 2021
The largest contextual study is the JAMA Internal Medicine pooled analysis by Mohan and colleagues, drawing on 191,558 participants from 58 countries across the PURE, ONTARGET, TRANSCEND, and ORIGIN cohorts [2]. Median follow-up was 9.1 years. In people without prior cardiovascular disease, fish intake showed no clear protective association — likely because background risk is low and a few servings per week aren't enough to move it. But in the 43,413 participants with prior vascular disease, eating at least 175 g/week of fish (roughly two servings) was associated with a meaningful reduction in major cardiovascular events and total mortality. The signal was strongest for oily fish with high omega-3 content, the category trout belongs to. This is consistent with the broader pattern — fish helps most where the cardiovascular machinery is already strained, which is where dietary omega-3 has the most plaque-stabilizing, antiarrhythmic, and triglyceride-lowering room to work.
Vitamin D content — Lu 2007
Lu and Holick's 2007 analysis in the Journal of Steroid Biochemistry and Molecular Biology directly measured vitamin D3 in commercially available fish using HPLC and tandem mass spectrometry [3]. Wild salmon averaged 988 ± 524 IU per 3.5 oz, farmed salmon dropped to 240 ± 108 IU (about a quarter of wild), and farmed rainbow trout came in at 388 ± 212 IU — higher than farmed salmon but well below wild salmon. The high standard deviations are worth noting: vitamin D content varies enormously even within a species depending on diet, life stage, and processing. The authors explicitly concluded that USDA food-composition tables for fish vitamin D are out of date. The practical takeaway is that trout is a reliable, if variable, dietary contributor to vitamin D — useful in winter months or for people who don't get much midday sun.
Astaxanthin in trout flesh — Rahman 2016
Rahman and colleagues fed juvenile rainbow trout four levels of dietary astaxanthin (0, 50, 75, and 100 mg/kg) for 10 weeks [4]. Muscle astaxanthin accumulated dose-dependently, and total antioxidant status in serum increased significantly at all supplemented doses versus control. Some specific antioxidant enzymes showed mixed responses — a reminder that "antioxidant capacity" in tissue is a multi-axis measure, not a single dial. The relevance for human eaters: the pink color of farmed trout flesh is a fairly direct readout of astaxanthin density, and farmed trout typically receives synthetic or Haematococcus pluvialis-derived astaxanthin in feed during the finishing period. Wild trout obtains it from invertebrate prey. Either way, a meaningful dose ends up on your plate — typically 1–6 mg per fillet, which is in the same order of magnitude as low-dose supplement studies of astaxanthin.
Federal recommendations — NIH ODS and FDA/EPA
The NIH Office of Dietary Supplements lists wild rainbow trout at 0.44 g EPA and 0.40 g DHA per 3-ounce cooked serving and reiterates the American Heart Association's recommendation of 1–2 servings of fatty fish per week for cardiovascular protection [5]. The joint FDA/EPA "Advice about Eating Fish" places trout — both freshwater and rainbow — in the Best Choices category, the lowest-mercury tier, recommending 2–3 servings per week including during pregnancy and breastfeeding [6]. The one caveat the agencies flag is that locally caught freshwater trout (especially from contaminated watersheds) may carry higher mercury or PCB loads than commercial product — local advisories should be checked.
Strength of the evidence
For trout specifically, the evidence base is narrower than for salmon, but the picture is consistent. One small but well-designed RCT shows whole-fish trout outperforms equivalent-dose fish-oil capsules on LDL [1]. Population-scale data on oily fish more broadly (which includes trout) shows secondary-prevention benefit at intakes of ~175 g/week or more [2]. Compositional studies confirm trout supplies clinically meaningful amounts of EPA, DHA, vitamin D, B12, selenium, and astaxanthin [3][4][5]. Federal regulators classify it as one of the safest fish to eat regularly [6]. The honest gap is in long-term hard-endpoint trials of trout specifically; almost all of the cardiovascular outcome evidence comes from oily-fish or omega-3-supplement trials, with trout treated as one member of the category. Given the nutrient density and low mercury, that's a defensible extrapolation, but it isn't proof of trout-specific benefit.